ACHC Investors with Losses Encouraged to Contact the Firm
San Francisco, California--(Newsfile Corp. - October 16, 2024) - Acadia Healthcare Co. Inc. (NASDAQ: ACHC) experienced a seismic jolt on September 27, as its stock price plummeted 16% following the disclosure of a government investigation into its patient treatment practices. The probe, initiated by the U.S. Department of Justice, comes in the wake of a damning New York Times report alleging that the company had engaged in coercive tactics to detain patients and inflate insurance reimbursements.
Hagens Berman urges Acadia Healthcare investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist the investigation to contact its attorneys.
Visit:www.hbsslaw.com/investor-fraud/ACHC
Contact the Firm Now:ACHC@hbsslaw.com
844-916-0895
Investigation into Acadia Healthcare Company, Inc. (ACHC):
On September 27, Acadia disclosed expanded federal investigations into its operations. The company revealed in a regulatory filing that it had received additional grand jury subpoenas and requests for information from federal prosecutors in New York and Missouri."
The latest developments come on the heels of a damning New York Times exposé published earlier in September, which accused Acadia of detaining patients against their will to boost revenue. The report detailed numerous instances of patients being held for financial rather than medical reasons, and cited evidence from dozens of patients, employees, and law enforcement officials
Prominent shareholder rights firm, Hagens Berman, has launched an investigation into potential securities fraud. The firm is examining whether the company may have misled investors about the true nature of its revenue growth and the propriety of its accounting practices.
Reed Kathrein, a partner at Hagens Berman, stated that the firm is "investigating whether Acadia may have misled investors about reasons for its revenue growth and about the propriety of its revenue recognition practices."
If you invested in Acadia Healthcare and have substantial losses, or have knowledge that may assist the firm's investigation, submit your losses now »
If you'd like more information and answers to frequently asked questions about the Acadia Healthcare investigation, read more »
Whistleblowers: Persons with non-public information regarding Acadia Healthcare should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email ACHC@hbsslaw.com.
# # #
About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/226879
